Johnson & Johnson

Johnson & Johnson is a pharmaceutical, medical device, and consumer packaged products company that was founded in 1886. As of 2020, this American multinational firm has over 132,000 workers and is based in New Brunswick, New Jersey, USA. It has over 250 subsidiaries in over 60 countries.

Johnson & Johnson has ranked first in revenue among the major biotech businesses since 2012. In 2019, the corporation made $82.059 billion in sales. Johnson & Johnson posted first-quarter sales of $20.7 billion on April 14, 2020, representing a robust 3.3 percent increase. The corporation made $18.3 billion and $21.1 billion in the second and third quarters of 2020, respectively. The impact of COVID-19 was reflected in a 10.8% drop in revenue in the second quarter. The strength of Johnson & Johnson's business model, the quality and breadth of their portfolio, and the company's constant commitment toward innovation are reflected in the company's 1.7 percent gain in the third-quarter financial report for 2020. Johnson & Johnson made $60.1 billion in sales in the first, second, and third quarters of 2020.

Amazing things are possible thanks to the mix of modern technology and their experience. J&J's consumer business is developing digital tools to help customers keep track of their skin's health. Medical device engineers are 3D printing prosthetic joints that are tailored for each patient, while pharmaceutical researchers are using AI to develop life-saving medications. Consider what the rest of their 134,000-strong staff at 260 firms in more than 60 countries is achieving. In today's environment, they redefine what it means to be a large corporation.

Founded: 1886

Headquarters: New Brunswick, NJ

Market Cap: 434.40B USD

Website: https://www.jnj.com/